Cargando…

CBP/p300 Bromodomains Regulate Amyloid-like Protein Aggregation upon Aberrant Lysine Acetylation

Lysine acetylation is becoming increasingly recognized as a general biological principle in cellular homeostasis, and is subject to abnormal control in different human pathologies. Here, we describe a global effect on amyloid-like protein aggregation in human cells that results from aberrant lysine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olzscha, Heidi, Fedorov, Oleg, Kessler, Benedikt M., Knapp, Stefan, La Thangue, Nicholas B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266481/ https://www.ncbi.nlm.nih.gov/pubmed/27989401 http://dx.doi.org/10.1016/j.chembiol.2016.11.009

Ejemplares similares

Protein Lysine Acetylation by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2015)

Correction to Protein Lysine Acetylation by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2016)

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
por: Hay, Duncan A., et al.
Publicado: (2014)

Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain
por: Chaikuad, Apirat, et al.
Publicado: (2016)

3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands
por: Hewings, David S., et al.
Publicado: (2011)

CBP / p300-mediated acetylation of histone H3 on lysine 56
por: Das, Chandrima, et al.
Publicado: (2009)

Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites
por: Vidler, Lewis R., et al.
Publicado: (2012)

Epigenetic mechanisms to propagate histone acetylation by p300/CBP
por: Kikuchi, Masaki, et al.
Publicado: (2023)

CBP/p300 Bromodomain Inhibitor–I–CBP112 Declines Transcription of the Key ABC Transporters and Sensitizes Cancer Cells to Chemotherapy Drugs
por: Strachowska, Magdalena, et al.
Publicado: (2021)

Is histone acetylation the most important physiological function for CBP and p300?
por: Bedford, David C., et al.
Publicado: (2012)

Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders
por: Valor, Luis M, et al.
Publicado: (2013)

Differential contribution of p300 and CBP to regulatory element acetylation in mESCs
por: Martire, Sara, et al.
Publicado: (2020)

Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancer
por: Hogg, Simon J., et al.
Publicado: (2022)

P300/CBP-Associated Factor Activates Cardiac Fibroblasts by SMAD2 Acetylation
por: Lim, Yongwoon, et al.
Publicado: (2021)

The CBP-1/p300 Lysine Acetyltransferase Regulates the Heat Shock Response in C. elegans
por: Barrett, Lindsey N., et al.
Publicado: (2022)

Domain-Independent Inhibition of CBP/p300 Attenuates α-Synuclein Aggregation
por: Hlushchuk, Irena, et al.
Publicado: (2021)

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
por: Conery, Andrew R, et al.
Publicado: (2016)

P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer
por: Cheng, Yin‐Wei, et al.
Publicado: (2021)

CBP and p300 acetylate PCNA to link its degradation with nucleotide excision repair synthesis
por: Cazzalini, Ornella, et al.
Publicado: (2014)

DYRK1A interacts with histone acetyl transferase p300 and CBP and localizes to enhancers
por: Li, Shanshan, et al.
Publicado: (2018)

Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
por: Conery, Andrew R, et al.
Publicado: (2016)

Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
por: Chen, Qingjuan, et al.
Publicado: (2022)

The HTLV-1-encoded protein HBZ directly inhibits the acetyl transferase activity of p300/CBP
por: Wurm, Torsten, et al.
Publicado: (2012)

Histone posttranslational modifications and cell fate determination: lens induction requires the lysine acetyltransferases CBP and p300
por: Wolf, Louise, et al.
Publicado: (2013)

Selective inhibition of BET bromodomains
por: Filippakopoulos, Panagis, et al.
Publicado: (2010)

Acetylation of histone H2B marks active enhancers and predicts CBP/p300 target genes
por: Narita, Takeo, et al.
Publicado: (2023)

Lysine Acetyltransferase p300/CBP Plays an Important Role in Reproduction, Embryogenesis and Longevity of the Pea Aphid Acyrthosiphon pisum
por: Kirfel, Phillipp, et al.
Publicado: (2020)

E2F1 acetylation directs p300/CBP-mediated histone acetylation at DNA double-strand breaks to facilitate repair
por: Manickavinayaham, Swarnalatha, et al.
Publicado: (2019)

A Read/Write Mechanism Connects p300 Bromodomain Function to H2A.Z Acetylation
por: Colino-Sanguino, Yolanda, et al.
Publicado: (2019)

Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
por: Ember, Stuart W. J., et al.
Publicado: (2014)

Molecular Lysine Tweezers Counteract Aberrant Protein Aggregation
por: Hadrovic, Inesa, et al.
Publicado: (2019)

The acetylation of transcription factor HBP1 by p300/CBP enhances p16(INK4A) expression
por: Wang, Weibin, et al.
Publicado: (2012)

Differences in Specificity and Selectivity Between CBP and p300 Acetylation of Histone H3 and H3/H4
por: Henry, Ryan A., et al.
Publicado: (2013)

Loss of p300 and CBP disrupts histone acetylation at the mouse Sry promoter and causes XY gonadal sex reversal
por: Carré, Gwenn-Aël, et al.
Publicado: (2018)

Promoter-specific changes in initiation, elongation, and homeostasis of histone H3 acetylation during CBP/p300 inhibition
por: Hsu, Emily, et al.
Publicado: (2021)

The histone acetyl transferases CBP and p300 regulate stress response pathways in synovial fibroblasts at transcriptional and functional levels
por: Krošel, Monika, et al.
Publicado: (2023)

Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma
por: Zhang, Xin, et al.
Publicado: (2020)

Curcumin, COX-2, and Protein p300/CBP
por: Jung, Ki Tae, et al.
Publicado: (2014)

Dimeric structure of p300/CBP associated factor
por: Shi, Shasha, et al.
Publicado: (2014)

Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain
por: Ferguson, Fleur M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3me9f5cf4lu6ripm9lj0rcjhci